Sulfotransferase inhibitors
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Jun 15, 2006
app pub date -
Jul 10, 2003
filing date -
Jul 10, 2002
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
A galactosamine derivative represented by the following formula (1): wherein R.sub.1, R.sub.2 and R.sub.5 each independently represents SO.sub.3.sup.- or H, and at least one of them represents SO.sub.3.sup.-; R.sub.3 represents H, acetyl or SO.sub.3.sup.-; R.sub.4 represents H, a substituted or unsubstituted alkyl group, a substituted or unsubstituted alkenyl group, a substituted or unsubstituted alkynyl group, a substituted or unsubstituted acyl group, a substituted or unsubstituted aryl group, or a substituted or unsubstituted aralkyl group; X represents O, S, NH or CH.sub.2; and represents an .alpha. bond or a .beta. bond, and a sulfotransferase inhibitor comprising the derivative.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully